Search - tctmd.com

Displaying 21 - 40 of 50

Sort: Relevancy | Date

News Conference News EuroPCR 2019

Newer-Generation MitraClip XTR Shows Promise, but Beware the Learning Curve

Shelley Wood

May 27, 2019

CHOICE: Better Hemodynamics, Less Structural Deterioration with CoreValve

News Conference News EuroPCR 2019

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

Michael O'Riordan

May 24, 2019

News Conference News EuroPCR 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Caitlin E. Cox

May 24, 2019

Presentation EuroPCR 2019

Mitral regurgitation severity predicts one year therapeutic benefit of Tendyne transcatheter mitral valve implantation

Presenter: Vinay Badhwar

May 22, 2019

News Conference News EuroPCR 2019

Clip-Based Tricuspid Repair Improves Regurgitation, Function, and Quality of Life: TRILUMINATE

Michael O'Riordan

May 22, 2019

Presentation EuroPCR 2019

The Mitral Valve Repair Clinical (MAVERIC) trial

Presenter: Simon Redwood

May 21, 2019

Presentation EuroPCR 2019

Leaflet edge-to-edge treatment versus direct annuloplasty in patients with functional mitral regurgitation

Presenter: Marcel Weber

May 21, 2019

Presentation EuroPCR 2019

Percutaneous Edge-To-Edge Repair In Patients With Heart Failure And Secondary Mitral Regurgitation PCR/EAPCI Statement

Presenter: Bernard Prendergast

May 21, 2019

Presentation EuroPCR 2019

Relationship Between Residual Mitral Regurgitation and Clinical and Functional Outcomes in the COAPT Trial

Presenter: Saibal Kar

May 21, 2019

News Conference News EuroPCR 2019

MR Reduction Linked to Lower HF Hospitalizations and Deaths, Regardless of Intervention: COAPT

Shelley Wood

May 21, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

Presentation EuroPCR 2018

CE Mark Study of Transcatheter Mitral Valve Replacement for Severe Mitral Regurgitation: 30 day outcomes of the first 100 patients

Presenter: David Muller

May 25, 2018

News Conference News EuroPCR 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Yael L. Maxwell

May 24, 2018

News Conference News EuroPCR 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Caitlin E. Cox

May 24, 2018

Presentation EuroPCR 2018

GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation (GIOTTO): Epidemiology and Acute Results

Presenter: Francesco Bedogni

May 23, 2018

News Conference News EuroPCR 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Caitlin E. Cox

May 17, 2017

News Conference News EuroPCR 2016

‘Europe Isn’t Waiting’: MitraClip Moves Into New Niches, Big and Small

Shelley Wood

May 26, 2016

News Conference News EuroPCR 2016

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Michael O'Riordan

May 23, 2016

News Conference News EuroPCR 2016

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests

Yael L. Maxwell

May 20, 2016

Advertisement

Newer-Generation MitraClip XTR Shows Promise, but Beware the Learning Curve

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Mitral regurgitation severity predicts one year therapeutic benefit of Tendyne transcatheter mitral valve implantation

Clip-Based Tricuspid Repair Improves Regurgitation, Function, and Quality of Life: TRILUMINATE

The Mitral Valve Repair Clinical (MAVERIC) trial

Leaflet edge-to-edge treatment versus direct annuloplasty in patients with functional mitral regurgitation

Percutaneous Edge-To-Edge Repair In Patients With Heart Failure And Secondary Mitral Regurgitation PCR/EAPCI Statement

Relationship Between Residual Mitral Regurgitation and Clinical and Functional Outcomes in the COAPT Trial

MR Reduction Linked to Lower HF Hospitalizations and Deaths, Regardless of Intervention: COAPT

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

CE Mark Study of Transcatheter Mitral Valve Replacement for Severe Mitral Regurgitation: 30 day outcomes of the first 100 patients

Pace Quickens for Mitral Device Innovation for Repair, Replacement

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation (GIOTTO): Epidemiology and Acute Results

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

‘Europe Isn’t Waiting’: MitraClip Moves Into New Niches, Big and Small

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content